You are here:
Access Gavi statements from 2013
07 December 2013
Pneumococcal vaccine to protect more than a million children in Afghanistan from leading child killer
Pneumonia accounts for 25% of deaths of children under five in Afghanistan each year.
06 December 2013
GAVI Alliance pays tribute to Nelson Mandela
Following the death of Nelson Mandela, Dagfinn Høybråten, Chair of the GAVI Alliance Board, and Dr Seth Berkley, CEO of the GAVI Alliance, issued statements
28 November 2013
Guillaume Grosso appointed head resource mobilisation in European markets
Former director of ONE Campaign’s Paris office joins GAVI Alliance.
26 November 2013
GAVI Alliance to support Nigeria's first new national yellow fever vaccination campaign in 30 years
Mass preventive campaign will protect close to 60 million children and adults.
07 November 2013
GAVI Alliance welcomes Germany’s continued commitment to immunisation
German support set to benefit East African Community and help improve supply chain.
05 November 2013
GAVI Alliance welcomes introduction of two life-saving vaccines in Senegal
Senegalese children to benefit from pneumococcal and measles-rubella vaccines .
24 October 2013
GAVI Alliance a top performer in leading transparency index
Commitment to transparency and data quality recognised.
22 October 2013
GAVI supports Cambodia’s campaign to vaccinate children against measles and rubella
More than four million children will receive the measles-rubella vaccine over the next three months.
09 October 2013
Vaccine to protect South Asian children against devastating disease set for GAVI support
Chinese vaccine industry enters world stage with WHO prequalified Japanese encephalitis vaccine
GAVI welcomes Canada's support for measles vaccines
GAVI welcomes Canada’s US$ 20 million pledge to accelerate access to measles vaccines.
08 October 2013
GAVI statement on latest trial data on malaria vaccine candidate RTS,S
Latest data published by Glaxosmithkline and PATH Malaria Vaccine Initiative
08 August 2013
GAVI responds to Medecins Sans Frontieres
In response to a press release issued by Medecins Sans Frontieres (MSF) on 8 August 2013, the GAVI Alliance issued the following statement
28 July 2013
Price reduced for vaccine against pneumococcal disease
The price the GAVI Alliance pays for lifesaving pneumococcal vaccines for children in the world’s poorest countries is set to be reduced under new agreements between GAVI, UNICEF, The World Bank, GlaxoSmithKline and Pfizer.
25 July 2013
Research shows high impact of Hib vaccines in developing countries
Results of Hib Initiative supplement published showing new evidence on the impact of Hib vaccines
18 July 2013
UK Government recognises GAVI's progress
The UK Department for International Development (DFID) confirms that the GAVI Alliance remains a highly effective organisation that is making progress on areas for improvement highlighted by the UK.
12 June 2013
GAVI Board asks to begin preparations for introduction of inactivated polio vaccine and considers investment in other new vaccines
The GAVI Alliance Board asks for in-depth analysis to inform its decisions on the future of GAVI’s vaccines portfolio and requests the GAVI Secretariat to develop a long-term strategy on how GAVI will support the introduction of Inactivated Polio Vaccine in partner countries.
30 May 2013
GAVI Alliance welcomes priority given to health and immunisation in High Level Panel Report
Statement from Dr Seth Berkley, CEO of the GAVI Alliance, following the publication of the report of the UN High Level Panel of Eminent Persons on the Post-2015 Development Agenda.
14 May 2013
Rotavirus leading cause of diarrhoea
The largest and most comprehensive study of childhood diarrhoea has confirmed rotavirus as the single biggest cause of diarrhoea-related death and illness in developing countries. This latest evidence suggests that a large number of children are dying from this vaccine-preventable pathogen, and supports the decision by the GAVI Alliance to prioritise rotavirus vaccines.
23 April 2013
GAVI responds to MSF campaign
In response to statements issued by Medecins Sans Frontieres, the GAVI Alliance has issued the following statement.
12 April 2013
Immunisation one key intervention to end two million preventable child deaths each year
Pneumonia and diarrhoea together account for nearly one-third of all under-five child deaths in developing countries. Evidence shows that children are dying from these preventable diseases because effective interventions are not reaching them or not provided equitably across all communities.
11 April 2013
GAVI review of health system strengthening in Sierra Leone
GAVI’s Transparency & Accountability Policy Team (TAP) has finalised its Audit of Health Systems Strengthening (HSS) in Sierra Leone and the findings have been officially communicated to the Government.
07 March 2013
Stronger protection for women and girls' health starts today
International Women's Day 2013 marks the beginning of a dramatic shift in the health of women and girls. Starting this year, GAVI is supporting the poorest countries of the world to roll out two vaccines that will directly benefit women and girls: human papillomavirus (HPV) against cervical cancer and rubella against 'German measles'.
25 February 2013
Statement on Ms Zainab Bangura and GAVI’s review of Sierra Leone
The GAVI Alliance has been requested by Ms Zainab Hawa Bangura, a former Minister of Health of Sierra Leone, to clarify certain details of its on-going review of GAVI Health Systems Strengthening (HSS) funding support to Sierra Leone.
11 February 2013
Attacks on health workers in Nigeria unacceptable
The GAVI Alliance joins the World Health Organization (WHO), UNICEF and the Government of Nigeria in condemning attacks in Nigeria which have killed and injured health workers.
30 January 2013
Simon Lamb appointed head of GAVI Internal Audit
The GAVI Alliance appoints Simon Lamb as Managing Director of Internal Audit. He succeeds Cees Klumper who has joined the Global Fund to Fight AIDS, Tuberculosis and Malaria.
20 January 2013
GAVI applauds exclusion of vaccines containing thiomersal as preservatives from mercury treaty
Delegates at the United Nations Environment Programme recognise the safety of thiomersal – a mercury-based vaccine preservative – and the critical role it plays in global health - by excluding it from a treaty on the release of mercury into the environment.
10 January 2013
GAVI recognised for effectiveness and focus on results
In its first ever Multilateral Organisation Performance Assessment Network (MOPAN) review the GAVI Alliance has been commended for its effectiveness in increasing access to immunisation and for its focus on results.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2017
modal window here